✦ LIBER ✦

Extensive clinical experience with taxotere (T) in 1st and 2nd line treatment in locally advanced or metastatic non small cell lung cancer (NSCLC)

✍ Scribed by Wilke, H; Von Pawel, J; Boon Cher, G; Krzakowski, M; Pirker, R; Morales, S; Avril, I; Manegold, C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extensive clinical experience with Taxot

✍ H. Wilke; J. Von Pawel; G.Boon Cher; M. Krzakowski; R. Pirker; S. Morales; D. To 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Extensive clinical experience with Taxot

✍ Wilke, H.; Joosens, E.; Hess, D.; Gozdz, S.; Cabral, S.; Orlandi, L.; Reksodiput 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 152 KB

83 Phase II study of docetaxel (Taxotere

✍ Le Chevalier, T.; Mattson, K.; Bosquée, L.; Le Groumellec, A.; Stupp, R.; Monnie 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 162 KB

P-474 Clinical experience of using docet

✍ Chowdhury, Q.; Hai, M.; Reza, M.; Islam, T. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

9068 Analysis of experience with cisplat

✍ Gamaz, M.; Bouzid, K. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Pemetrexed single agent chemotherapy in

✍ Francesca Russo; Alessandra Bearz; Gianni Pampaloni; the investigators of the It 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 238 KB